Related Practice Life Sciences & Pharma Orphan drugs are expected to play an increasingly prominent role in the biopharmaceutical industry. The worldwide orphan market grew at ~8 percent per year over the past five years (from $79B to $114B). 08052019090827
Published Articles Life Sciences & Pharma The Growth of Radiotherapeutics: Addressing Supply Chain Complexity May 21, 2025
Case Study Life Sciences & Pharma Building Resilience in a Commercial-Stage Pharma Company’s Supply Chain April 16, 2025
Executive Insights Life Sciences & Pharma Radiotherapeutics on the Rise: Addressing Supply Chain Complexity April 7, 2025
Podcast Life Sciences & Pharma A New Generation of Drug Therapies Requires New Business Strategies July 10, 2024